Kate Haviland, CHIEF EXECUTIVE OFFICER at Blueprint Medicines Corp (BPMC), sold 13,068 shares at $45.72 ($597K) on 2023-03-06, disclosed to the SEC on 2023-03-08.
Seasonal sale ($597k) by CHIEF EXECUTIVE OFFICER — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.65 | 212 | $9K | 1.6% |
| 2 | $45.72 | 6,428 | $294K | 49.2% |
| 3 | $45.72 | 6,428 | $294K | 49.2% |
| Total | $45.70 avg | 13,068 | $597K | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |